Adderall (mixed amphetamine salts) is a Schedule II controlled substance under the U.S. Controlled Substances Act, requiring a valid prescription from a DEA-registered healthcare provider for ADHD or narcolepsy after comprehensive diagnostic evaluation. No automatic refills allowed; providers may issue up to 90-day supply via multiple dated prescriptions, but states often limit to 30 days with PDMP checks.
Psychiatrists, primary care physicians, neurologists, or nurse practitioners conduct in-person or telehealth evaluations (Ryan Haight Act compliant through 2025) confirming diagnosis via standardized assessments before issuing e-prescriptions. Submit to NABP-verified pharmacies using EPCS systems for secure dispensing; legitimate telehealth requires state-specific registration
Be the first to donate!